BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Tamoxifen
,
rs2300478
,
BRAF
,
T cell differentiation
,
Inflammatory disorder
,
Pancreas
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
potassium channel- complex
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Potassium and Calcium Channel Complexes as Novel Targets for Cancer Research.
Distinct white matter integrity in glutamic acid decarboxylase and voltage-gated potassium channel-c…
Creutzfeldt-Jakob Disease-Like Periodic Sharp Wave Complexes in Voltage-Gated Potassium Channel-Comp…
Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic …
Chronic pain as a manifestation of potassium channel-complex autoimmunity.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Sodium Channel Splicing in Obstructive Sleep Apnea (SOCS-OSA)
Study of Immunotherapy in Autoantibody Positive Psychosis
IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy
Acute Mechanical Response to Anti-arrhythmic Drug Therapy
Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ